| Business Summary | | Virbac,
Inc.
develops,
manufactures,
markets,
distributes
and
sells
a
variety
of
pet
and
companion
animal
health
products,
focusing
on
dermatological,
parasiticide
and
dental
products.
The
Company's
PM
Resources
division
(PMR),
based
in
Bridgeton,
Missouri,
formulates
products
under
private-label
and
third-party
contract
manufacturing
for
use
in
the
animal
health
and
specialty
chemicals
industries.
Some
of
the
Company's
products
are
manufactured
and
distributed
under
license
from
Virbac
S.A.
(VBSA),
a
French
veterinary
pharmaceutical
manufacturer
that
indirectly
owns
approximately
60%
of
the
Company's
outstanding
common
stock.
The
Company
distributes
and
sells
its
products
throughout
the
United
States
and
Canada
and,
through
a
distribution
agreement
with
VBSA,
in
foreign
markets. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Virbac
manufactures
and
distributes
a
wide
variety
of
animal
health
care
products
focusing
on
dermatological,
parasiticide
and
dental
products.
For
the
six
months
ended
6/01,
net
revenues
increased
21%
to
$31
million.
Net
income
before
accounting
change
increased
13%
to
$1.1
million.
Revenues
reflect
the
introduction
of
new
products.
Net
income
was
partially
offset
by
increased
R&D
expenses
due
to
costs
incurred
to
obtain
the
registration
to
sell
the
Company's
new
products. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Pascal Boissy, 58 Chairman | -- | -- | Thomas Bell, 42 Pres,
CEO | $227K | -- | Joseph Rougraff, 42 CFO,
VP | 81K | -- | Bruce Baker, 57 Exec.
VP - Bus. Devel. | 207K | $269K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|